Verano Posts $218M Revenue in Q2 2026 Amid Mixed Profitability
Event summary
- $218M revenue in Q2 2026, up 5% sequentially and 8% year-over-year.
- Gross profit margin declined to 46% from 56% year-over-year.
- Net loss narrowed to $13.4M from $19.2M year-over-year.
- Adjusted EBITDA of $51M, down from $66M in Q2 2025.
- Completed a 1-for-5 reverse stock split and authorized $20M stock repurchase.
The big picture
Verano's Q2 2026 results highlight the tension between revenue growth and profitability in the cannabis sector. The company's strategic moves, including a reverse stock split and DEA registration efforts, reflect broader industry trends toward regulatory clarity and capital market engagement. With operations spanning 13 states and over 160 dispensaries, Verano's ability to balance expansion with cost management will be critical.
What we're watching
- Profitability Pressures
- Whether Verano can sustain gross margin recovery amid rising SG&A expenses.
- Regulatory Shifts
- How the rescheduling of cannabis from Schedule I to III impacts Verano's strategic positioning.
- Capital Allocation
- The pace at which Verano executes its stock repurchase and retail expansion plans.
Related topics